Back
Harmony Biosciences Holdings Vs. Exelixis Industry Stock Comparison
Buy
82
HRMY
Harmony Biosciences Holdings
Last Price:
31.65
Seasonality Move:
3.71%
Sell
46
EXEL
Exelixis
Last Price:
21.58
Seasonality Move:
8.31%
Buy
82
Harmony Biosciences Holdings (HRMY)
is a Buy
Is Harmony Biosciences Holdings a Buy, Sell or Hold?
- The current Harmony Biosciences Holdings [HRMY] share price is $31.70. The Score for HRMY is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- HRMY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
46
Exelixis (EXEL)
is a Sell
Is Exelixis a Buy, Sell or Hold?
- The current Exelixis [EXEL] share price is $21.59. The Score for EXEL is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- EXEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRMY Stock Price Chart
What is Harmony Biosciences Holdings's stock price today?
-
The Harmony Biosciences Holdings share price today is $31.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HRMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
HRMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 56.64 | Buy |
| Chaikin Money Flow: | 371129 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.16 - 31.08) | Buy |
| Bollinger Bands (100): | (30.32 - 33.08) | Sell |
EXEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 35.89 | Sell |
| Chaikin Money Flow: | -2043669 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.22 - 23.54) | Sell |
| Bollinger Bands (100): | (21.54 - 23.64) | Sell |
HRMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.95 | Buy |
| 20-day SMA: | 30.05 | Buy |
| 50-day SMA: | 31.06 | Buy |
| 200-day SMA: | 31.15 | Buy |
| 8-day EMA: | 30.97 | Buy |
| 20-day EMA: | 30.6 | Buy |
| 50-day EMA: | 30.91 | Buy |
| 200-day EMA: | 32.35 | Sell |
EXEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.35 | Sell |
| 20-day SMA: | 22.74 | Sell |
| 50-day SMA: | 22.94 | Sell |
| 200-day SMA: | 21.98 | Sell |
| 8-day EMA: | 22.23 | Sell |
| 20-day EMA: | 22.65 | Sell |
| 50-day EMA: | 22.72 | Sell |
| 200-day EMA: | 21.79 | Sell |
Harmony Biosciences Holdings Earnings Growth & HRMY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.11 per share, an increase this year of $0.64 per share, and an increase next year of $1.54 per share.
Exelixis Earnings Growth & EXEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.01 per share, an increase this year of $0.53 per share, and an increase next year of $0.33 per share.
Harmony Biosciences Holdings Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Exelixis Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||